- Home
- RMI vs ME Comparison
RMI vs ME Comparison
Compare RMI & ME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMI
- ME
- Stock Information
- Founded
- RMI 2018
- ME 2006
- Country
- RMI United States
- ME United States
- Employees
- RMI N/A
- ME N/A
- Industry
- RMI Finance/Investors Services
- ME Precision Instruments
- Sector
- RMI Finance
- ME Health Care
- Exchange
- RMI Nasdaq
- ME Nasdaq
- Market Cap
- RMI 95.7M
- ME 98.7M
- IPO Year
- RMI N/A
- ME N/A
- Fundamental
- Price
- RMI $15.47
- ME $3.61
- Analyst Decision
- RMI
- ME Hold
- Analyst Count
- RMI 0
- ME 1
- Target Price
- RMI N/A
- ME $9.40
- AVG Volume (30 Days)
- RMI 17.4K
- ME 234.3K
- Earning Date
- RMI 01-01-0001
- ME 02-05-2025
- Dividend Yield
- RMI 7.28%
- ME N/A
- EPS Growth
- RMI N/A
- ME N/A
- EPS
- RMI N/A
- ME N/A
- Revenue
- RMI N/A
- ME $193,260,000.00
- Revenue This Year
- RMI N/A
- ME $21.93
- Revenue Next Year
- RMI N/A
- ME $17.31
- P/E Ratio
- RMI N/A
- ME N/A
- Revenue Growth
- RMI N/A
- ME N/A
- 52 Week Low
- RMI $13.05
- ME $2.66
- 52 Week High
- RMI $17.37
- ME $16.52
- Technical
- Relative Strength Index (RSI)
- RMI 54.54
- ME 50.49
- Support Level
- RMI $15.34
- ME $3.34
- Resistance Level
- RMI $15.54
- ME $4.18
- Average True Range (ATR)
- RMI 0.16
- ME 0.30
- MACD
- RMI 0.07
- ME 0.02
- Stochastic Oscillator
- RMI 90.45
- ME 48.65
About RMI RiverNorth Opportunistic Municipal Income Fund Inc.
RiverNorth Opportunistic Municipal Income Fund, Inc. is a diversified, closed-end management investment company. Its investment objective is to seek current income exempt from regular U.S. federal income taxes. The Fund's secondary investment objective is total return.
About ME 23andMe Holding Co.
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.